Keaton Piper

Keaton Piper

Auto-generated profile, based on publicly available information

Keaton Piper

Department of Neurosurgery, University of South Florida, Tampa, Florida; and

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Surgical Neurology International
Verified
Journal Article
Open access
KPKeatonF Piper
KeatonF Piper
STSamuelB Tomlinson
SamuelB Tomlinson
GSGabrielle Santangelo
Gabrielle Santangelo
JGJoseph Van Galen
Joseph Van Galen
IDIan DeAndrea-Lazarus
Ian DeAndrea-Lazarus
EVEdward Vates
Edward Vates
Wound complications, including surgical site infections (SSIs) and wound dehiscence, are among the most common complications following spine surgery often leading to readmission. The authors sought to identify preoperative characteristics predictive of wound complications after spine surgery. The American College of Surgeons National Surgical Quality Improvement Program database for years 2012-2014 was reviewed for patients undergoing spine surgery, defined by the Current Procedural Terminology codes. Forty-four preoperative and surgical characteristics were analyzed for associations with wound complications. Of the 99,152 patients included in this study, 2.2% experienced at least one wound complication (superficial SSI: 0.9%, deep SSI: 0.8%, organ space SSI: 0.4%, and dehiscence: 0.3%). Multivariate binary logistic regression testing found 10 preoperative characteristics associated with wound complications: body mass index ≥30, smoker, female, chronic steroid use, hematocrit 3 hours. A risk score for each patient was created from the number of characteristics present. Receiver operating characteristic curves of the unweighted and weighted risk scores generated areas under the curve of 0.701 (95% CI: 0.690-0.713) and 0.715 (95% CI: 0.704-0.726), respectively. Patients with unweighted risk scores >7 were 25-fold more likely to develop a wound complication compared to patients with scores of 0. In addition, mortality rate, reoperation rate, and total length of stay each increased nearly 10-fold with increasing risk score. This study introduces a novel risk score for the development of wound dehiscence and SSIs in patients undergoing spine surgery, using new risk factors identified here.

1 November 2017 in World Neurosurgery
Verified
Journal Article
Closed access
STSamuel B. Tomlinson
Samuel B. Tomlinson
KPKeaton Piper
Keaton Piper
KKKristopher T. Kimmell
Kristopher T. Kimmell
GVG. Edward Vates
G. Edward Vates

1 February 2018 in World Neurosurgery
Verified
Journal Article
Closed access
KPKeaton Piper
Keaton Piper
IDIan DeAndrea-Lazarus
Ian DeAndrea-Lazarus
HAHanna N. Algattas Hanna N. Algattas
Hanna N. Algattas Hanna N. Algattas
KKKristopher T. Kimmell
Kristopher T. Kimmell
JTJames Towner
James Towner
GVGeorge E. Vates
George E. Vates

21 May 2024 in Neuro-Oncology
Verified
Journal Article
Open access
PDF file
KPKeaton Piper
Keaton Piper
JKJay Kumar
Jay Kumar
JDJoseph Domino
Joseph Domino
CTChad Tuchek
Chad Tuchek
MVMichael Vogelbaum
Michael Vogelbaum
Drug delivery to the central nervous system (CNS) has been a major challenge for CNS tumors due to the impermeability of the blood-brain barrier (BBB). There has been a multitude of techniques aimed at overcoming the BBB obstacle aimed at utilizing natural transport mechanisms or bypassing the BBB which we review here. Another approach that has generated recent interest in the recently published literature is to use new technologies (Laser Interstitial Thermal Therapy, LITT; or Low-Intensity Focused Ultrasound, LIFU) to temporarily increase BBB permeability. This review overviews the advantages, disadvantages, and major advances of each method. LIFU has been a major area of research to allow for chemotherapeutics to cross the BBB which has a particular emphasis in this review. While most of the advances remain in animal studies, there are an increasing number of translational clinical trials that will have results in the next few years.

28 May 2020 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
JBJan-Karl Burkhardt
Jan-Karl Burkhardt
VSV. Srinivasan
V. Srinivasan
ASA. Srivatsan
A. Srivatsan
FAF. Albuquerque
F. Albuquerque
ADAndrew F Ducruet
Andrew F Ducruet
PKP. Kan
P. Kan
BACKGROUND AND PURPOSE: The Neuroform Atlas is a new microstent to assist coil embolization of intracranial aneurysms that recently gained FDA approval. We present a postmarket multicenter analysis of the Neuroform Atlas stent. MATERIALS AND METHODS: On the basis of retrospective chart review from 11 academic centers, we analyzed patients treated with the Neuroform Atlas after FDA exemption from January 2018 to June 2019. Clinical and radiologic parameters included patient demographics, aneurysm characteristics, stent parameters, complications, and outcomes at discharge and last follow-up. RESULTS: Overall, 128 aneurysms in 128 patients (median age, 62 years) were treated with 138 stents. Risk factors included smoking (59.4%), multiple aneurysms (27.3%), and family history of aneurysms (16.4%). Most patients were treated electively (93.7%), and 8 (6.3%) underwent treatment within 2 weeks of subarachnoid hemorrhage. Previous aneurysm treatment failure was present in 21% of cases. Wide-neck aneurysms (80.5%), small aneurysm size (<7 mm, 76.6%), and bifurcation aneurysm location (basilar apex, 28.9%; anterior communicating artery, 27.3%; and middle cerebral artery bifurcation, 12.5%) were common. A single stent was used in 92.2% of cases, and a single catheter for both stent placement and coiling was used in 59.4% of cases. Technical complications during stent deployment occurred in 4.7% of cases; symptomatic thromboembolic stroke, in 2.3%; and symptomatic hemorrhage, in 0.8%. Favorable Raymond grades (Raymond-Roy occlusion classification) I and II were achieved in 82.9% at discharge and 89.5% at last follow-up. mRS ≤2 was determined in 96.9% of patients at last follow-up. The immediate Raymond-Roy occlusion classification grade correlated with aneurysm location (P < .0001) and rupture status during treatment (P = .03). CONCLUSIONS: This multicenter analysis provides a real-world safety and efficacy profile for the treatment of intracranial aneurysms with the Neuroform Atlas stent.

1 April 2021 in World Neurosurgery
Verified
Journal Article
Closed access
KPKeaton Piper
Keaton Piper
MRMaximilian Rabil
Maximilian Rabil
DCDavid Ciesla
David Ciesla
SASivero Agazzi
Sivero Agazzi
ZRZeguang Ren
Zeguang Ren
WGWaldo R. Guerrero
Waldo R. Guerrero